The Venture Codex Logo

The Venture Codex

Quest Diagnostics

500 Plaza Drive, Secaucus, NJ, 07094, United States

Overview

Healthcare diagnostics and laboratory services provider.

Founded

1967

Deals · 12mo

0

Links

WebsiteLinkedInX (Twitter)

Stage focus

Series B

Geographic focus

Australia
Spain
United States

Sector focus

Biotechnology
Health Care
Health Diagnostics
Information Services
...

Investment portfolio

5rounds
NAMEDATESIZE
PreciseDx
Jun 2025Participated
$11 MOther Equity
PreciseDx
Aug 2024Participated
$21 MSeries B
Freenome
Feb 2024Participated
$254 MOther Equity
Universal Diagnostics
Nov 2023Led
$70 MSeries B
Clinical Genomics Technologies
Jun 2018Participated
$26 MOther Equity
PreciseDx
Jun 2025Participated
$11 MOther Equity
PreciseDx
Aug 2024Participated
$21 MSeries B
Freenome
Feb 2024Participated
$254 MOther Equity
Universal Diagnostics
Nov 2023Led
$70 MSeries B
Clinical Genomics Technologies
Jun 2018Participated
$26 MOther Equity
5
Items
Browse all public portfolio deals

Insights

Time horizon

View by

Deal Distribution

Quest Diagnostics: 5 funding rounds are recorded in the selected participation categories.All available history.
Quest Diagnostics: 5 funding rounds are recorded in the selected participation categories. All available history
Round typeLed dealsParticipated deals
Series B11
Other Equity03

Monthly Deal Activity

Quest Diagnostics: 5 deals are recorded across 101 months.All available history.
Quest Diagnostics: 5 deals are recorded across 101 months. All available history
MonthDeals
Jun '181
Jul '180
Aug '180
Sep '180
Oct '180
Nov '180
Dec '180
Jan '190
Feb '190
Mar '190
Apr '190
May '190
Jun '190
Jul '190
Aug '190
Sep '190
Oct '190
Nov '190
Dec '190
Jan '200
Feb '200
Mar '200
Apr '200
May '200
Jun '200
Jul '200
Aug '200
Sep '200
Oct '200
Nov '200
Dec '200
Jan '210
Feb '210
Mar '210
Apr '210
May '210
Jun '210
Jul '210
Aug '210
Sep '210
Oct '210
Nov '210
Dec '210
Jan '220
Feb '220
Mar '220
Apr '220
May '220
Jun '220
Jul '220
Aug '220
Sep '220
Oct '220
Nov '220
Dec '220
Jan '230
Feb '230
Mar '230
Apr '230
May '230
Jun '230
Jul '230
Aug '230
Sep '230
Oct '230
Nov '231
Dec '230
Jan '240
Feb '241
Mar '240
Apr '240
May '240
Jun '240
Jul '240
Aug '241
Sep '240
Oct '240
Nov '240
Dec '240
Jan '250
Feb '250
Mar '250
Apr '250
May '250
Jun '251
Jul '250
Aug '250
Sep '250
Oct '250
Nov '250
Dec '250
Jan '260
Feb '260
Mar '260
Apr '260
May '260
Jun '260
Jul '260
Aug '260
Sep '260
Oct '260

Sector Breakdown

Quest Diagnostics: Health & Life Sciences is the largest displayed sector by deal count (5 deals).All available history.

A deal can appear in multiple sectors, so sector totals may overlap. Capital represents disclosed total round sizes, not fund cheque sizes.

Quest Diagnostics: Health & Life Sciences is the largest displayed sector by deal count (5 deals). All available history
SectorDeals
Health & Life Sciences5

Deal Size Distribution

Quest Diagnostics: 5 rounds have a disclosed size in the displayed size bands.All available history.

Undisclosed round sizes are excluded. Capital represents total round sizes, not fund cheque sizes.

Quest Diagnostics: 5 rounds have a disclosed size in the displayed size bands. All available history
Round size band (USD)Deals
<$5M0
$5M-$10M0
$10M-$25M2
$25M-$50M1
$50M-$100M1
$100M-$250M0
$250M-$500M1
$500M-$1B0
$1B+0

Deals By Geography

Quest Diagnostics: United States has the largest recorded deal count among the displayed regions (3 deals).All available history.

Top 3 of 3 regions; European countries are grouped as Europe.

Quest Diagnostics: United States has the largest recorded deal count among the displayed regions (3 deals). All available history
RegionDeals
United States3
Europe1
Australia1
Quest Diagnostics: 20 co-investors are shown, with Eventide Asset Management sharing 3 recorded deals.All available history.

Co-Investors

Bubble size = shared deals

Click a bubble to open that fund in a new tab.

Shows up to 20 co-investors ranked by shared deals. Deals may be shared with multiple funds, so rows overlap. Capital is total round size, not fund cheque size.

Quest Diagnostics: 20 co-investors are shown, with Eventide Asset Management sharing 3 recorded deals. All available history
Co-investorShared deals
Eventide Asset Management3
GenHenn Capital2
Labcorp2
American Cancer Society1
Andreessen Horowitz1
ARK Invest1
ArrowMark Partners1
ARTIS Ventures1
Bain Capital Life Sciences1
Cormorant Capital1
Data Collective1
Intermountain Ventures1
MA Financial1
Merck1
OneVentures1
Perceptive Advisors1
Philips Ventures1
Polaris Partners1
Pura Vida Investments1
RA Capital Management1

Investment Strategy

Quest Diagnostics: Led accounts for 20% and participating for 80% of round participation.All available history.
Quest Diagnostics: Led accounts for 20% and participating for 80% of round participation. All available history
CategoryDeals (count)Share (%)
Led120%
Participating480%
Quest Diagnostics: Single-lead accounts for 100% and co-led for 0% of lead dynamics.All available history.
Quest Diagnostics: Single-lead accounts for 100% and co-led for 0% of lead dynamics. All available history
CategoryDeals (count)Share (%)
Single-lead1100%
Co-led00%

Team

Angelo DiPreta

Executive Sales Director

Chaarles Fogelgren

Executive Director, Pharma and Diagnostic Services

Denny Moynihan

Executive Director

Lidia Fonseca

Senior Vice President and Chief Information Officer

Mark A. Gardner

senior vice president

Paul Brown

Founder & Connectivity Operations Manager

Robert Burton

Sr Manager Product Research and Development

Yuri Fesko

Senior Vice President and Chief Medical Officer

Yvette Desmarais

Senior Data Governance Specialist